grade cervical lesions

Related by string. * GRADES . Grades . grades . GRADE . Grade : Carrier Grade . eighth grade . Ninth Grade . Eighth Grade / CERVICAL . Cervical : causes cervical cancer . cervical cancer screening . cervical cancer precursors . cervical cancer screenings / Lesions . Lesion . lesioned : metastatic lesions . target lesion revascularization . benign lesions . pigmented lesions rejuvenate * *

Related by context. All words. (Click for frequent words.) 70 grade cervical dysplasia 67 grade cervical intraepithelial 65 grade glioma 64 grade squamous intraepithelial 63 cervical intraepithelial neoplasia 63 dose oral contraceptive 63 dose cyclophosphamide 63 grade prostatic intraepithelial 62 molecular weight heparins 62 systemic toxicity 62 cervical lesions 62 grade gliomas 61 FORTESTA Gel 61 weight heparin LMWH 61 risk HPV genotypes 61 cervical dysplasia 60 Molecular Weight Heparin 60 dose ritonavir 60 dose dexamethasone 60 Cervista HPV HR 60 CIN3 59 CIN2 + 59 dose colchicine 59 dose Iluvien 59 dose ionizing radiation 59 premalignant lesion 59 neutrophil counts 59 neoplasia CIN 59 epithelial tumors 58 CIN2 58 HER2 expression 58 precancerous cervical 58 ano genital warts 58 epithelial ovarian cancer 58 operable breast cancer 58 pretest probability 58 malignant ascites 58 hENT1 58 specific antigen PSA 58 vaginal lesions 58 transdermal estradiol 58 skeletal metastases 58 platelet reactivity 58 serum LDL cholesterol 58 intraepithelial neoplasia 58 dose cytarabine 58 nucleotide analog 58 dose corticosteroids 58 ovarian carcinoma 58 relapsed MM 57 precancerous cervical lesions 57 recurrent genital herpes 57 nanomolar 57 dose cohort 57 HER2 overexpression 57 dose interleukin 57 recurrent metastatic 57 bioavailable testosterone 57 B7 H3 57 dexamethasone Decadron 57 macrolide antibiotic 57 artery embolization 57 dose melphalan 57 chlamydial infection 57 ASCUS 57 protease inhibitor PI 57 nanomolar range 57 E selectin 57 serum concentrations 57 endometrial carcinoma 57 laser therapy LLLT 57 anthracycline chemotherapy 57 systemic bioavailability 57 ertapenem 57 genital herpes infections 57 serum urate levels 57 chloride secretion 57 PSA nadir 57 topical microbicide 57 GARDASIL ® 56 AGHD 56 node metastases 56 intravesical therapy 56 protease inhibitors PIs 56 HGPIN 56 endometrial hyperplasia 56 RhD 56 prostate cancer CaP 56 FullTerm 56 #.#ng/ml 56 precursor lesions 56 lactate dehydrogenase 56 locoregional recurrence 56 prostate carcinoma 56 NRTI backbone 56 clodronate 56 ritonavir boosted 56 serum urate 56 Erlotinib 56 CERVARIX 55 antibody titer 55 gastric carcinoma 55 Prostate Specific Antigen PSA 55 Gleevec resistant 55 fluvastatin 55 epithelial ovarian 55 Squamous 55 candidemia 55 dose atorvastatin 55 PCA3 scores 55 vaginal cancers 55 interferon alfa 2b 55 treat menorrhagia 55 neoplasia 55 thyroid stimulating hormone 55 thyroglobulin 55 recurrent ovarian 55 cervical carcinoma 55 LNG IUS 55 tTG 55 urothelial bladder cancer 55 Neisseria gonorrhoeae 55 smoldering multiple myeloma 55 luteal 55 antiandrogens 55 CMV infection 55 lipid elevations 55 metastatic neuroendocrine tumors 55 thyrotropin 55 cervical vulvar 55 expressors 55 Recombinant interferon alpha 55 histologic subtype 55 mRCC 55 caspofungin 54 Zolinza 54 quadrivalent vaccine 54 ara C 54 chlamydial 54 RhD negative 54 N. gonorrhoeae 54 advanced adenomas 54 amikacin 54 clenbuterol prohibited 54 invasive ductal 54 Vidaza azacitidine 54 dysplastic lesions 54 liposomal amphotericin B 54 intradermal injection 54 HBeAg negative 54 Heavy menstrual bleeding 54 abnormal pap smears 54 chronic periodontitis 54 piperacillin tazobactam 54 Human papillomavirus HPV 54 invasive candidiasis 54 miRview ™ squamous 54 antigen PSA 54 SCIg 54 HBeAg seroconversion 54 inhibitor RG# 54 ductal breast cancer 54 Human papillomavirus 54 Pelvic Inflammatory Disease 54 genotype 1b 54 genital ulcers 54 HER-2/neu 54 colorectal carcinoma 54 HPV genotypes 54 basal cell carcinoma BCC 54 VivaGel ™ 54 IgM antibodies 54 T#I [002] 54 vulvar vaginal 54 gastric adenocarcinoma 54 Posaconazole 54 castrate resistant 54 dose Ara 54 seroconversion 54 external genital lesions 54 adenoma recurrence 54 serum TSH 54 ARB telmisartan 54 recurrent ovarian cancer 54 abnormal cytology 54 Fetal Fibronectin Test 54 metastatic malignant 54 glycated hemoglobin levels 54 hepatocellular carcinomas 54 baseline LDH 54 dysplastic lesions caused 54 pmol L 54 HPV-#/# 54 IV bisphosphonates 54 cervical vaginal 54 myeloperoxidase 54 thyroid carcinoma 54 subcutaneously injected 54 invasive carcinoma 54 Dacogen decitabine 54 intensity pulsed ultrasound 54 hepatitis C HCV 53 etanercept Enbrel 53 penetrance 53 Interferon beta 1b 53 cancerous cervical lesions 53 carcinoembryonic antigen 53 micafungin 53 ovary uterus 53 IOP lowering 53 guaiac 53 HER2 amplification 53 mg/m2 dose 53 PPAR gamma agonists 53 monoclonal anti 53 dimeglumine 53 Immunohistochemical analysis 53 serum creatinine levels 53 MALT lymphoma 53 anogenital warts 53 antigen PSA levels 53 NNRTIs 53 grade astrocytomas 53 gastrointestinal stromal tumors GIST 53 density lipoprotein cholesterol 53 Parathyroid Hormone 53 HBsAg 53 HbF 53 doxorubicin docetaxel 53 atazanavir Reyataz 53 NNRTI resistant virus 53 nonnucleoside reverse transcriptase inhibitors 53 colorectal adenoma 53 BCG vaccinated 53 WT1 53 hyperoxaluria 53 chlorambucil 53 myoma 53 transabdominal 53 hA# 53 atypical ductal hyperplasia 53 certolizumab 53 uterine cervix 53 HC2 test 53 hematologic toxicity 53 eosinophil count 53 Digene HPV Test 53 dose naltrexone 53 thyroid hormone levels 53 SPIRIVA ® 53 reactogenicity 53 rFSH 53 urine albumin 53 cytological 53 Candida infections 53 histological subtype 53 serum IgE 53 pCR 53 LSIL 53 Adhibit 53 molecular remissions 53 colorectal liver metastases 53 Noxafil 53 μg liter 53 Kinoid 53 BARACLUDE ® 53 alanine aminotransferase ALT 53 K#N 53 Dasatinib 53 moderate immunologic 53 Tindamax R 53 isoenzyme 53 Conjugate Vaccine 53 porcine derived 53 transgene expression 53 basal cell nevus syndrome 53 trimethoprim sulfamethoxazole 53 SGPT 53 nucleoside analogues 53 detect precancerous lesions 52 pain CLBP 52 Nilotinib 52 imatinib Gleevec 52 oral herpes 52 plasma albumin 52 precancerous tumors 52 alemtuzumab treated 52 efavirenz Sustiva 52 BufferGel 52 HER2/neu 52 mycophenolate mofetil 52 systemic corticosteroids 52 TPV r 52 antibody titers 52 HER2 ErbB2 52 prostate specific 52 abacavir Ziagen 52 selective agonist 52 mutated K ras 52 meropenem 52 serogroup B 52 pathogenic viruses 52 familial hypercholesterolemia FH 52 apolipoprotein B 52 delafloxacin 52 breast carcinoma 52 urethritis 52 HER2 positive cancers 52 herpes zoster shingles 52 p# biomarker 52 troponin T 52 quadrivalent HPV vaccine 52 serum IGF 52 trichomonas 52 indinavir 52 IU ml 52 serum potassium 52 CD4 + T lymphocytes 52 G CSFs 52 neoplasias 52 AST ALT 52 HPV# 52 biochemical relapse 52 azacytidine 52 pancreatic ovarian 52 tuberculin skin testing 52 steroid dexamethasone 52 pT3 52 endocrine therapies 52 axillary lymph nodes 52 IgG antibody 52 gonococcal infection 52 hydroxyvitamin D levels 52 Viral Load 52 serum IgG 52 human papilloma 52 intraductal 52 tumoral 52 malignant polyps 52 Cervista HPV 52 venous blood clots 52 K ras mutations 52 IFN beta 52 hemoglobin Hb 52 biochemical recurrence 52 osteosarcomas 52 hamartoma 52 Immunohistochemical staining 52 SUVmax 52 abnormal pap tests 52 salmeterol fluticasone 52 Combination therapy 52 Omiganan 52 pelvic malignancies 52 antibiotic azithromycin 52 CsA 52 adalimumab Humira 52 homocysteine concentrations 52 5-FU/LV 52 EpCAM 52 atypical hyperplasia 52 nmol liter 52 glomerular filtration 52 lumbar spine BMD 52 PASI scores 52 PEG IFN 52 transcriptase inhibitors NNRTIs 52 ritonavir boosted lopinavir 52 latent tuberculosis TB 52 undetectable viral 52 prophylactic vaccine 52 noninferior 52 submucosal 52 viral titers 52 Rev Dex 52 fluconazole resistant 52 Chlamydia trachomatis infection 52 octreotide LAR 52 cytomegalovirus CMV 52 Abacavir 52 Candida infection 52 anti HBs 52 acid phosphatase PAP 52 NAbs 52 lymphoid tumors 52 PURE proprietary 52 renal cell carcinomas 52 invasive aspergillosis 52 genital tract 51 urothelial carcinoma 51 cell carcinomas 51 adefovir dipivoxil 51 IgA antibodies 51 residual platelet reactivity 51 gemcitabine cisplatin 51 NNRTI 51 Lenalidomide 51 efavirenz EFV 51 genotypic resistance 51 bacterial vaginosis BV 51 BMPR2 51 antimicrobial prophylaxis 51 amphotericin B 51 symptomatic intracranial hemorrhage 51 P. falciparum malaria 51 undetectable HBV DNA 51 hsCRP levels 51 Peginterferon 51 ABCB1 51 poliovirus vaccine 51 precancers 51 hemoglobin A1c levels 51 gastrointestinal stromal tumors GISTs 51 timolol maleate 51 TMP SMX 51 pg ml 51 fFN 51 NRTI resistance 51 JAK2 V#F 51 mupirocin 51 Epivir 51 prostate pancreatic 51 colorectal cancer CRC 51 MenACWY 51 inecalcitol 51 throughput RNAi 51 anogenital 51 entecavir 51 alkaline phosphatase 51 density lipoprotein HDL cholesterol 51 beta interferons 51 antithrombotic agent 51 Human Papilloma Virus 51 Pegylated interferon 51 E7 proteins 51 femoral neck BMD 51 oncogenic HPV types 51 mammographic density 51 serum homocysteine 51 Flu Cy 51 KRAS mutations occur 51 FDG uptake 51 thrombogenic 51 beta lactamase inhibitor 51 endometrial 51 trastuzumab Herceptin 51 nicardipine 51 uterus fallopian tubes 51 dihydrochloride 51 leiomyomas 51 intestinal polyps 51 complete cytogenetic response 51 D dimer 51 interferon γ 51 bovine thrombin 51 tigecycline 51 ovarian pancreatic 51 seminoma 51 heavy menstrual bleeding 51 hepatorenal syndrome 51 endometrial cancers 51 Helicobacter pylori H. pylori 51 ROTARIX 51 conventional cytology 51 sentinel lymph nodes 51 vaginal atrophy 51 elevated CRP 51 abnormal Pap tests 51 Pap smear screening 51 contralateral breast 51 peptide antigens 51 aspartate aminotransferase 51 premalignant 51 mutated KRAS gene 51 S/GSK# 51 latent tuberculosis infection 51 Duodenal 51 parasitemia 51 dose oral contraceptives 51 Toxoid 51 cervical precancer 51 prostate adenocarcinoma 51 metastatic prostate 51 BRCA mutation carriers 51 atherosclerotic lesions 51 Malignant Melanoma 51 Human Papilloma Virus HPV 51 circulating lymphocytes 51 induce ovulation 51 angiotensin converting enzyme inhibitors 51 mucinous 51 NNRTI resistance 51 Adenomas 51 titres 51 ABC/3TC 51 HCV replicon 51 penile cancers 51 Velcade bortezomib 51 differentiated thyroid 51 anagrelide 51 CXCR4 expression 51 serous ovarian cancer 51 lymphopenia 51 Chlamydia infection 51 HNSCC 51 CCR5 tropic HIV 50 μg ml 50 ADPKD 50 chronic HBV 50 leiomyoma 50 low dose Iluvien 50 nonvaccine 50 orchiectomy 50 Kaletra lopinavir ritonavir 50 Copegus ribavirin 50 pegIFN 50 colorectal neoplasms 50 urate levels 50 completely resected 50 anal lesions 50 leucopenia 50 Human Papillomavirus 50 fructose diet 50 PHPT 50 tryptase 50 sonographically 50 mL/min/#.# m 2 50 ximelagatran 50 FluCAM arm 50 virologic failure 50 hypertensives 50 alanine aminotransferase 50 pimecrolimus cream 50 Trichomonas vaginalis 50 breast carcinomas 50 Pegasys peginterferon alfa 2a 50 H Pylori 50 tipranavir r 50 neoplastic lesions 50 antiviral efficacy 50 adenomatous polyp 50 abnormal Pap 50 pelvic lymphadenectomy 50 leukocyte count 50 cytoreductive surgery 50 pegylated interferon alfa 50 nanomolar potency 50 CMV disease 50 sustained virologic response 50 CLL SLL 50 anal cancers 50 idraparinux 50 comparator arm 50 genital lesions 50 radiosensitivity 50 B Cell Lymphoma 50 cinacalcet 50 TMC# r 50 HSV2 50 transvaginal ultrasound 50 cytokeratin 50 GISTs 50 low expressors 50 Allogeneic 50 RAS mutations 50 inhibitory concentrations 50 varicella zoster virus VZV 50 abnormal Pap smears 50 quadrivalent human papillomavirus 50 EpCAM expression 50 specific antigen 50 cervical cytology 50 immunostaining 50 neuroblastoma tumors 50 albumin excretion rate 50 metastatic lesions 50 vaginal microbicides 50 bronchoalveolar lavage 50 necrotic core 50 inner foreskin 50 uterine abnormalities 50 p# antigen 50 sDNA 50 IGFBP 3 50 enterococcal 50 pre cancerous lesions 50 C. trachomatis 50 nonproliferative 50 quinolone 50 Human Papillomavirus HPV 50 recurrent UTI 50 pentoxifylline 50 intracranial hemorrhage ICH 50 radezolid 50 liver histology 50 polycystic ovary syndrome PCOS 50 SLNB 50 leukocytosis 50 herpes zoster vaccine 50 dysmenorrhoea 50 benign noncancerous 50 interferon alfa 50 iPTH 50 pelvic lymph nodes 50 Quiescent current 50 serum phosphorus levels 50 axilla 50 Adefovir 50 receiving Vectibix monotherapy 50 anterior uveitis 50 intranasally administered 50 Elevated serum 50 tissue transglutaminase 50 interferon α 50 breast abscesses 50 severe rotavirus gastroenteritis 50 genital tract infections 50 orchitis 50 T1a 50 wart virus 50 perianal 50 GSTP1 50 acromegalic patients 50 palivizumab 50 elevated triglyceride levels 50 isoprostane 50 receptor blocker 50 polypoid 50 ovarian breast 50 interferon ribavirin 50 emissions combustor 50 hereditary breast cancer 50 APTIVUS R 50 granulocyte 50 HER2 receptor 50 HPV subtypes 50 UGT#A# 50 fluticasone salmeterol 50 emtricitabine tenofovir 50 YERVOY 50 squamous 49 BRCA deficient 49 amniotic fluid leakage 49 calcified plaques 49 leukaemias 49 GSTT1 49 CIN3 + 49 receiving highly emetogenic 49 HCV genotype 49 mcg mL 49 multiple gestations 49 endometrial ovarian 49 serum lipid levels 49 seroconverted 49 sonographic guidance 49 #mmHg [001] 49 postpartum bleeding 49 albumin excretion 49 tenofovir DF 49 adnexal mass 49 Endometrial cancer 49 monoinfected patients 49 throughput gene expression 49 malignant growths 49 Bone Mineral Density 49 osteoprotegerin 49 Haptoglobin 49 Enterobacter cloacae 49 solar keratosis 49 canakinumab 49 glans penis 49 titers 49 IgG1 49 input capacitance 49 human papillomaviruses HPV 49 seronegative 49 precancerous condition 49 microg 49 elevated LDH 49 low dose ritonavir 49 μmol L 49 ug mL 49 Menveo 49 hepatitis B virus HBV 49 lipoprotein 49 malignant nodules 49 colorectal polyp 49 PCR assay 49 Bacillus Calmette Guerin BCG 49 rs# [001] 49 virologic responses 49 extracranial 49 inhibitory concentration 49 ductal cancer 49 breast lesions 49 repigmentation 49 HER2 positive breast cancer 49 amenorrhoea 49 estrogen receptor ER 49 hepatocellular cancer 49 decitabine 49 Bacterial Vaginosis 49 progesterone hormone 49 BRAF mutation 49 tacrolimus ointment 49 fosamprenavir 49 bFGF 49 DAS# CRP 49 tertile 49 abnormal pap 49 pg mL 49 de novo AML 49 capsular polysaccharide 49 immunoreactivity 49 pneumococcal infection 49 cervical cancer screening 49 parasitaemia 49 eflornithine 49 acne blemishes 49 μg mL 49 daunorubicin 49 vaccine TIV 49 amoxicillin clavulanate 49 pegylated IFN 49 Aptivus ® 49 sustained virological response 49 intact parathyroid hormone 49 Platelet Counts 49 bactericidal activity 49 achieved sustained virological 49 lymphocytosis 49 serum antibody 49 pancreatic lung 49 GCase 49 Tenofovir DF 49 bacterium Chlamydia trachomatis 49 euthyroid 49 imipenem 49 viral kinetics 49 #.#mmol L [002] 49 adenomatous polyps 49 invasive lobular 49 vulvar lesions 49 chlamydia trachomatis 49 CMV infections 49 gestational diabetes mellitus GDM 49 bacterial vaginosis 49 Thrombin 49 titer 49 bacterium Neisseria meningitidis 49 misdemeanor Alderden 49 Molecular Weight Heparins 49 oncogenic HPV 49 cephalosporin antibiotics 49 transaminase elevations 49 intensity sweetener sucralose 49 IntelliAD 49 HCV antibody 49 bacillus Calmette Guerin 49 seroprotection 49 abnormal cervical 49 glulisine 49 Cytomegalovirus CMV 49 HPV types 49 urethral stricture 49 HbA1C 49 buccal mucosa 49 oesophageal 49 rapid virological response 49 malignant lymphoma 49 prostate cancer metastases 49 polysaccharide vaccine 49 cidofovir 49 Interferon alfa 49 inconclusive Pap 49 ovarian uterine 49 TT genotype 49 pegylated interferon alpha 49 leukopenia 49 endometrial lining 49 P aeruginosa 49 deletion 5q 49 Lymphocytic 49 PCa 49 thrombocytopenic 49 Moxifloxacin 49 colorectum 49 pre cancerous 49 IgG4 49 ALT elevation 49 peritoneal cancer 49 newly acquired UnoMobi 49 pessary 49 immunochemical fecal occult 48 bladder carcinoma 48 imiquimod cream 48 Engerix B 48 pertussis Tdap vaccine 48 microbiological eradication 48 adnexal masses 48 paraoxonase 48 lupus anticoagulant 48 Neulasta pegfilgrastim 48 supine hypertension 48 hormonal therapy 48 amino acid homocysteine 48 noise amplifiers LNAs 48 abnormal vaginal bleeding 48 colon carcinoma 48 fluoroquinolone resistance 48 GABHS 48 Immune responses 48 Protease Inhibitors 48 Respiratory Syncytial Virus RSV 48 echocardiographic parameters 48 HPVs 48 FLT3 48 cervical breast 48 keratoses 48 monophasic 48 fat vegan diet 48 genital wart 48 noise amplifier LNA 48 LV dysfunction 48 Papanicolaou Pap 48 BALB c mice 48 Troponin T 48 medullary thyroid cancer 48 impair fertility 48 bone metastasis 48 HIV uninfected 48 chronic hepatitis cirrhosis 48 warfarin dosage 48 abnormal Pap test 48 urinary calcium excretion 48 excisional biopsy 48 Fluzone Intradermal vaccine 48 phosphorylcholine 48 conjugate vaccine 48 pancreatic adenocarcinoma 48 favorable tolerability 48 HBV infection 48 mmol liter 48 neutralizing antibody 48 pelvic inflammatory disease 48 hemoglobin concentrations 48 moderately emetogenic 48 plasminogen activators 48 RCMA supports 48 lopinavir r arm 48 severe periodontitis 48 serum ferritin 48 cefotaxime 48 mIU L 48 LDL Cholesterol 48 Epstein Barr virus EBV 48 sulfasalazine 48 vaginitis 48 Her2/neu 48 colonoscopic 48 ovulatory cycles 48 ganciclovir ophthalmic gel 48 procalcitonin 48 mcg dose 48 oxacillin 48 Epidermal Growth Factor Receptor 48 locoregional disease 48 Prolastin C 48 plasmid DNA vaccine 48 sitosterol 48 safety tolerability pharmacokinetic 48 lymphoid organs 48 dose statin therapy 48 S. aureus isolates 48 mIU ml 48 corpus luteum 48 BRACAnalysis ® 48 CCyR 48 atypia 48 heFH 48 Serologic 48 methicillin sensitive 48 fluorouracil leucovorin 48 conserved antigens NP 48 precancerous tissue 48 vaginal flora 48 Virologic 48 idiopathic myelofibrosis 48 viraemia 48 heparanase 48 4CMenB 48 seropositive 48 combination antiretroviral therapy 48 intraocular 48 cervical neoplasia 48 serogroup 48 prostate walnut 48 cervical biopsies 48 immunosuppressives 48 QbG# 48 seropositive patients 48 needle aspiration 48 cutaneous squamous cell carcinoma 48 ERalpha 48 FOLFIRI alone 48 cellularity 48 detemir 48 Delcath novel 48 bladder prostate 48 glycemic index foods 48 EGFR mutation 48 transfusion syndrome 48 neutropenic 48 endocervical 48 ischemic lesions 48 ductal carcinomas 48 hydronephrosis 48 cervical cancer genital warts 48 ESBLs 48 pseudoaneurysm 48 paraffin embedded tissue 48 adenoma 48 anemia hemoglobin 48 antiangiogenic drugs 48 induced cytotoxicity 48 valacyclovir 48 NMP# 48 alcohol refreshers 48 BRCA1 mutation carriers 48 PCA3 48 PAP smear 48 limiting toxicity DLT 48 antibody titres 48 preventing precancerous lesions 48 HER2 48 lobular carcinoma 48 lymph node dissection 48 rizatriptan 48 pT2 48 macrolide resistance 48 Synflorix 48 intestinal metaplasia 48 Chlamydia infections 48 acellular pertussis vaccine 48 rectal microbicides 48 HbF levels 48 neurofibromas 48 endometrial ablation 48 oral Hycamtin 48 viremia 48 squamous cell carcinoma SCC 48 nonmelanoma skin cancers 47 pertussis tetanus 47 vaginal pH 47 uM 47 polymyxin B 47 Epstein Barr Virus EBV 47 Ki# 47 thymidine kinase 47 hormone receptor positive 47 HCV genotypes 47 ultrasonographic examination 47 preventing genital warts 47 BRCA mutation 47 colposcopic 47 Streptococcus pyogenes 47 Amniocentesis 47 pulmonary arterial pressures 47 clobetasol 47 Hb A1C 47 log# copies mL 47 K#R [002] 47 triglyceride concentrations 47 clade B 47 Ishak fibrosis score 47 diabetes mellitus DM 47 MCV4 47 endometrial biopsies 47 choriocarcinoma 47 thiazides 47 ovarian endometrial 47 LTBI 47 Hepatitis B Virus 47 carcinomas 47 AMN# [001] 47 mucosal tissue 47 timepoints 47 Hepatitis B HBV 47 tract infections 47 ALCL 47 breast ovarian 47 adjuvanted vaccines 47 viral conjunctivitis 47 Genital HPV 47 metastatic prostate cancer 47 #.#mg dose 47 ELISpot 47 latent celiac disease 47 Molecular Weight

Back to home page